000 | 01922 a2200529 4500 | ||
---|---|---|---|
005 | 20250513211150.0 | ||
264 | 0 | _c20000621 | |
008 | 200006s 0 0 eng d | ||
022 | _a0268-3369 | ||
024 | 7 |
_a10.1038/sj.bmt.1702243 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTimmers, G J | |
245 | 0 | 0 |
_aAmphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial. _h[electronic resource] |
260 |
_bBone marrow transplantation _cApr 2000 |
||
300 |
_a879-84 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAmphotericin B _xadministration & dosage |
650 | 0 | 4 |
_aBilirubin _xblood |
650 | 0 | 4 | _aConsumer Product Safety |
650 | 0 | 4 | _aContraindications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluconazole _xadministration & dosage |
650 | 0 | 4 |
_aHematologic Neoplasms _xcomplications |
650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfusions, Intravenous _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMorphine _xtherapeutic use |
650 | 0 | 4 |
_aMycoses _xdrug therapy |
650 | 0 | 4 |
_aNeutropenia _xcomplications |
650 | 0 | 4 |
_aRespiratory Tract Diseases _xchemically induced |
650 | 0 | 4 | _aShivering |
650 | 0 | 4 | _aSurvival |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTransaminases _xblood |
700 | 1 | _aZweegman, S | |
700 | 1 | _aSimoons-Smit, A M | |
700 | 1 | _avan Loenen, A C | |
700 | 1 | _aTouw, D | |
700 | 1 | _aHuijgens, P C | |
773 | 0 |
_tBone marrow transplantation _gvol. 25 _gno. 8 _gp. 879-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1702243 _zAvailable from publisher's website |
999 |
_c10760074 _d10760074 |